Blood Collection Biorepository for Liver Disease Research

Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · Jan 18, 2017

Keywords

ClinConnect Summary

This clinical trial is focused on collecting blood samples to help researchers better understand liver diseases, particularly conditions like Non-Alcoholic Steatohepatitis (NASH), hepatitis, and fatty liver. The goal is to create a biorepository, which is a collection of high-quality samples such as serum and liver tissue, that scientists can use for future studies. This research is important because it aims to uncover how these diseases affect the liver, potentially leading to better treatments in the future.

If you or your child are between the ages of 25 and 56 and have liver diseases or even if you don't have any liver issues, you might be eligible to participate. However, this study is not open to vulnerable groups such as infants, pregnant women, or individuals who cannot provide consent. Participants will simply provide blood samples, and there are no treatments or medications involved. Your contributions could play a vital role in advancing our understanding of liver health!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
• • Children and teenagers will be special populations considered in this protocol.
• Exclusion Criteria:
• • Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.